A SERVICE
ANNOUNCEMENT FROM:
ACT


   

EXL Pharma
ExL Pharma Proudly Presents:
5th Trial Design Innovation
July 13-14, 2010 - Sheraton National Hotel - Arlington, VA
MORE INFORMATION

Keynote Presentation:
The Dichotomy of Adaptive Design
Exploring the Positives and Negatives of Adaptive Design with the Intent on Making Product Development More Flexible and Efficient

Stuart Pocock, PhD SPEAKER:
Stuart Pocock, PhD
Professor of Medical Statistics
LONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE

5 case studies throughout clinical trial process

FDA Adaptive Design Draft Guidance Review/Impact:

REVIEW: The FDA Discusses Details behind the Recent Draft Guidance on Adaptive Trials as well as the Thought Process behind their Decisions
FDA Invited

IMPACT: Pharma Representatives Discussing The Impact of the Recent Guidance and What Changes Have Been Put in Place to in Order to Remain Compliant

PANELISTS:

  • Michael Krams, Senior Vice President, Head of Neurology Franchise, JOHNSON & JOHNSON
  • Henry Foehl, Senior Statistician, CSL BEHRING
  • Darcy Hille, Senior Biometrician, MERCK & CO
  • Bob Noble, Discovery Biometrics, GLAXOSMITHKLINE

click here to register

For information on exhibiting & sponsorship opportunities, please contact Lucas Carrasco at 212-400-6231 or lcarrasco@exlpharma.com

 




CLICK HERE to download a conference brochure

conference brochure image

Sponsors: Addplan, Cytel, UBC

Join the discussion
Click here to join our Adaptive Clinical Trials group on LinkedIn:

linkedin logo


If you no longer wish to receive emails from EXL Pharma, Please reply HERE

ACT is published by Advanstar Communications, 485 Rt 1 South, Iselin, NJ 08830.
This is an advertisement sent on behalf of this advertiser.